Member Info for davidpqz

Some say that zinc and lead haven't been invited to the super cycle party due to over supply. As for copper I'm invested in Atalya which in my humble opinion is undervalued despite the price of copper having been elevated for most of the year and is likely to go higher.

The price of zinc has just broken $3k/mt. However, there seem to be mixed messages on whether to expect zinc to remain in surplus. Any insights?

Steady on! Polygon increased their holding from 10% to 11%. That's a 1% increase worth roughly £3.5m.

Any other theories ?

They have chosen the soft comparative in 2020. EBITDA is £m-2.92 and in 2019 was £m-3.55; in 2020 £m -7.66 !

I suspect the share price is being adversely affected by the Chinese threat to start auctioning part of its strategic copper reserve . World consumption is about 24.5 million metric tonnes. Estimates of China's reserves vary between 2 million and 26 million. One is insignificant, the other isn't!
Any views?

There is an excellent article in the current (28 May-3 June) Investors Chronicle on SLP by Simon Thompson. In short, the price of rhodium looks well supported by the move to electric vehicles and other developments.

The Chinese are taking a political posture. Short term it may have some effect; longer term if they (don't) put their money where their mouth is, they will damage the Chinese economy and I don't see that happening.

The share price can be driven by intrinsic value or market sentiment. As has been said before Mr Market is a crazy fellow. The question you have to answer is has has he been too pessimistic or is he now being wildly optimistic. Send me £5 and I'll tell you what I think.

Thanks, this is a terrific resource. Those worried by $25k rhodium might find some reassurance from the chart on p.26.

China may be able to make life hell for Uighurs but despite their posturing they can't buck the markets.

There was a minor equity markets shake out today on inflation fears but I see that ATYM held steady. If there's a knee jerk drop in our sp then I'll take that as a buy signal as there is no weakness in the price of copper - currently around $4.79/lb

I've been trying to figure out what this might be and have included some quotes from Futura's website. In the case of TIB200 it's clear that evaporation produces a super concentration of the Ibuprofen active ingredient and this somehow forces it through the skin.
Unless I am mistaken no such active ingredient is named for MED3000.
Am I missing something?

TIB200
Volatile solvents evaporate, leaving the remaining solvent supersaturated with ibuprofen.
Supersaturation drives ibuprofen rapidly through the skin.

MED3000 is a topical gel which utilises our proprietary technology DermaSys®,  developed specifically for treatment of ED.  MED3000 has the potential to be a highly differentiated product by addressing significant unmet needs in the ED market.

Of DermaSys itself it says:

“Our versatile transdermal technology DermaSys® is tailored for each product to suit the specific therapeutic indication ….

Mr DC. the RNS you speak of could be as early as this week . Someone pointed out that the Q1 financials were published on May 15 last year.
When I plug estimates for the average copper price for this year into my spreadsheet, the lowest share price it predicts (other things remaining stable) is £8.
Disclaimer: I've been wrong before!

This recent (today) article is interesting: https://www.marketwatch.com/story/iron-ore-prices-hit-record-high-with-appetite-for-steel-far-beyond-expectations-11620320569
The forward PE is 4.3 according to Stockopedia so if you're concerned about the price then on this basis I would say this is still very cheap despite the recent strong rise.
China is cracking down on polluting steelmakers which has increased the demand for FXPO's less polluting high quality 65% Fe pellets in addition to the strong rise in demand for iron ore.
The recent massing of Russian forces intimidated some investors but I think that threat is retreating especially with the new Biden presidency.
I'm buying some more this morning which is probably your best reason for not investing !

The copper price has recently risen very strongly. On this basis the net profit for Atalaya should have increased by multiples and yet the share price stubbornly refuses to go any higher - this might be another miner to have a look at.
In general there does seem to be a sp lag with miners. The attraction is that they are a leveraged play on the commodity price (any rise goes to the bottom line pretty much, less tax) but the market doesn't react until enough profits have accumulated and then you can see a sudden upwards jump in the share price. Many commentators are confident that higher metal prices are here to stay for the foreseeable future (even excluding Goldman Sachs' "super cycle" theory).
50 grand is quite a chunk so I'd drip feed it and spread it around -there's no such thing as certainty in investing!

Thanks Toptiger. You could well be right. I did get the impression that it is fairly lightly traded.

Does anyone know of a reliable source for this? Kitco seems to give only historical data, Matthey similar but very customisable. There are others, one of whom is quoting $17,800 per Oz which I'm praying is wrong! Google give $29,500 but when you click on the link (which opens MetalsDaily) the quote is $29,300. Any ideas on where to find a reliable real time price?

In 2020 the all-in sustaining cost was $2.21 per lb. while the average realised selling price was $2.72 per lb. Profit for the year was €m 30.39. The price of copper is currently around $4.5 so ...

That's why I bought them a few months ago! They are offering consultancy via the internet, so partners in Australia etc. may as well be next door. There is a huge backlog of elective work in the NHS so I'm expecting them to renew their pre-covid growth trajectory.

On the Proactive interview it was stated that final approval will take 4 to 6 weeks. I would expect a decline in the sp over that period but I'm not inclined to sell . I'm not saying the situation is identical but viagra made $2bn per annum for its first few years on the market. That's why when the good news breaks here, it will already be too late. (I have been wrong before).